TRAM Snapshot of App at Pub for Oppostn

RANDOX DISCOVERY

Randox Laboratories Ltd

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 88318383 FILING DATE 02/27/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY CIURPITA, DREW PETER F
L.O. ASSIGNED 114

PUB INFORMATION

RUN DATE 12/07/2019
PUB DATE N/A
STATUS 680-APPROVED FOR PUBLICATION
STATUS DATE 12/06/2019
LITERAL MARK ELEMENT RANDOX DISCOVERY

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D YES 44D NO 44D NO
44E NO 44E YES 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT RANDOX DISCOVERY
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Randox Laboratories Ltd
ADDRESS Ardmore
Diamond Road
Crumlin, Antrim, BT294QY
ENTITY 99-limited company (ltd.)
CITIZENSHIP GB5

GOODS AND SERVICES

INTERNATIONAL CLASS 001
          DESCRIPTION TEXT Diagnostic preparations for scientific purposes; chemical reagents for scientific or medical research and for use in the analysis of food products; enzymes for use in scientific and medical research applications; protein arrays for use in scientific and medical research applications; diagnostic preparations for analysis of food products and water for scientific or research use; clinical diagnostic preparations for clinical or medical laboratory use; clinical diagnostic reagents for in vitro use for clinical or medical laboratory use; chemical reagents other than for medical or veterinary purposes, namely, chemical reagents for detection and monitoring of disease states in vitro for laboratory research purposes; diagnostic proteins, namely, protein arrays for scientific and medical research featuring antibodies and antigens used for monitoring of disease states in vitro
INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Diagnostic preparations and substances for medical and veterinary purposes; diagnostic kits in the nature of clinical chemistry and immunology test kits for medical use in the detection and monitoring of disease states in vitro, namely, chemical reagents for medical or veterinary purposes for the detection and monitoring of disease states including cardiac, DOA, stroke, metabolic, cancer, diabetes, fertility, thyroid and DNA arrays; clinical diagnostic preparations, for medical or veterinary use; clinical diagnostic reagents for in vivo use for medical or veterinary purposes; diagnostic scanning agents for in vivo use for medical or veterinary purposes; diagnostic testing materials for medical use in the detection and monitoring of disease states in vitro, namely, chemical reagents for medical or veterinary purposes for the detection and monitoring of disease states including cardiac, DOA, stroke, metabolic, cancer, diabetes, fertility, thyroid and DNA arrays; medical diagnostic proteins, namely, protein arrays for medical diagnostic purposes featuring antibodies and antigens used for medical detection of disease states in vitro; chemical reagents, namely, chemical reagents for detection and monitoring of disease states in vitro
INTERNATIONAL CLASS 009
          DESCRIPTION TEXT Downloadable computer software for use in conjunction with in vitro diagnostic testing apparatus, namely, software for controlling medical and clinical sample processing, sample result reporting and test apparatus system robotics; computer hardware for or relating to the analysis, monitoring, research and/or reporting of clinical data; downloadable computer programs for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systems, namely, computer hardware and downloadable software for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systems for use in conjunction with in vitro diagnostic testing apparatus, namely, downloadable computer software and hardware for controlling medical and clinical sample processing; downloadable computer databases and computer databases recorded on computer media for use in connection with in vitro diagnostic testing apparatus, namely, downloadable electronic data files featuring medical diagnostic sample results; scientific and optical apparatus and instruments, namely, a benchtop analytical system composed of barcode scanner and associated software for reading barcodes, a chemiluminescent detection system in the nature of instruments for measuring chemiluminescence, a temperature controlled incubator for laboratory use, and an electronic reagent and patient sample dispenser, suitable for protein and DNA arrays for or relating to the analysis, monitoring, research and/or reporting of clinical data, for use in vitro diagnostic testing procedures for clinical, veterinary, food and toxicological analysis; clinical analyzers not for medical and veterinary use, namely, acidity analyzers, liquid analyzers, residual gas analyzers for use in vitro diagnostic testing procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs for laboratory use; light detectors for use in vitro diagnostic testing procedures, namely, a chemiluminescence detection system not for medical purposes; parts and fittings for all the aforesaid goods, namely, replacement parts and fittings
INTERNATIONAL CLASS 010
          DESCRIPTION TEXT Medical apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins and hormones; diagnostic apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; diagnostic imaging apparatus for medical use, namely, electromechanical diagnostic analyser utilizing a chemiluminescent detection system for use in in vitro diagnostic testing procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; medical diagnostic testing apparatus and instruments for use in immunoassay procedures, namely, for use in the measurement of antibodies, immunoglobulins, hormones and drugs representing various drug classes; light detectors for use in vitro diagnostic testing procedures, namely, a chemiluminescence detection system for medical purposes; clinical analyzers for medical and veterinary use, namely, acidity analyzers, liquid analyzers, residual gas analyzers for use in vitro diagnostic testing procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 001 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 009 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 010 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

FOREIGN INFORMATION

PRIORITY CLAIMED SEC. 44(D) ON United Kingdom
APPLICATION NO. 3379045
APPLICATION FILING DATE 02/27/2019
FOREIGN REG NO. UK0000337904
FOREIGN REG DATE 07/19/2019
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION 02/27/2029
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
12/06/2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 017
12/05/2019 XAEC I EXAMINER'S AMENDMENT ENTERED 016
12/05/2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED 015
12/05/2019 GNEA O EXAMINERS AMENDMENT E-MAILED 014
12/05/2019 CNEA R EXAMINERS AMENDMENT -WRITTEN 013
10/22/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 012
10/22/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 011
10/15/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 010
05/15/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 009
05/15/2019 GNRT F NON-FINAL ACTION E-MAILED 008
05/15/2019 CNRT R NON-FINAL ACTION WRITTEN 007
05/08/2019 DOCK D ASSIGNED TO EXAMINER 006
03/19/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 005
03/11/2019 AMPX O APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED 004
03/11/2019 ALIE A ASSIGNED TO LIE 003
03/06/2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED 002
03/02/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Daniel Frohling
CORRESPONDENCE ADDRESS Daniel Frohling
LOEB & LOEB LLP
321 North Clark Street
Suite 2300
Chicago, IL 60654
DOMESTIC REPRESENTATIVE NONE

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed